Nicola Pozzi: A New Mechanism to Reduce Thrombus Formation Without Increasing Bleeding Risk
Nicola Pozzi, Associate Professor of Saint Louis University School of Medicine, shared a post on LinkedIn:
“From structure, to function, to proof-of-concept therapeutic. A brand-new mechanism to reduce thrombus formation without increasing bleeding risk inspired by our research on Antiphospholipid Syndrome (APS).ss
Extremely proud of this work, how it has evolved over the years and the incredible people involved (Marisa Brake, PhD, Suresh Kumar, PhD Catherine Lapointe, Glenn Merrill-Skoloff, Sol Schulman, Matthew Flick, and Robert Flaumenhaft at Harvard Medical School, Saint Louis University School of Medicine and Blood Research Center at UNC)
We believe this approach has great potential, and we’re excited to moving it forward. Also, here’s an interesting research question. Are all autoantibodies bad? Early to say but maybe not all of them are…”
Title: In vivo targeting of open prothrombin with the monoclonal antibody POmAb results in anticoagulation without excessive bleeding
Authors: Marisa A. Brake, Suresh Kumar, Catherine Lapointe, Glenn Merrill-Skoloff, Sol Schulman, Matthew J. Flick, Robert Flaumenhaft, Nicola Pozzi
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment